Completed
Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin
NCT00382798
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
- Locations
-
- Quest Clinical Research San Francisco, California, United States
- University of Colorado Health Sciences Center Aurora, Colorado, United States
- University of Florida Gainesville, Florida, United States
- Orlando Immunology Center Orlando, Florida, United States